Smith Karen L.
SEC insider (Form 3/4/5 filer). CIK 0001639637. Director at Context Therapeutics Inc. (CNTX) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in PHILADELPHIA, PA.
Companies Smith Karen L. has filed insider reports for
- Context Therapeutics Inc. (CNTX): Director
- Skye Bioscience, Inc. (SKYE): Director
- SANGAMO THERAPEUTICS, INC (SGMO): Director
- Aurinia Pharmaceuticals Inc. (AUPH): Director
Smith Karen L.
CIK: 0001639637
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 24, 2026CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
45K shares- - Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
75K shares- - Feb 6, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
35K shares- - Jun 12, 2025SGMO
SANGAMO THERAPEUTICS, INC
AwardDirect25K shares- - Jun 12, 2025CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
123.5K shares- - Feb 24, 2025SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
35K shares- - Nov 21, 2024AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect12.1K shares- - Nov 11, 2024AUPH
Aurinia Pharmaceuticals Inc.
SaleDirect5.2K shares at avg. $8.43$44K - Nov 8, 2024AUPH
Aurinia Pharmaceuticals Inc.
ExerciseDirect17.9K shares- - Oct 28, 2024SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
70K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  CNTX Context Therapeutics Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Mar 31, 2026 |  SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Feb 6, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Jun 12, 2025 |  SGMO SANGAMO THERAPEUTICS, INC | Award | 25,000 | - | - | Direct |
| Jun 12, 2025 | CNTX Context Therapeutics Inc. | Award Stock Option (right to buy) | 123,500 | - | - | Direct |
| Feb 24, 2025 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Nov 21, 2024 |  AUPH Aurinia Pharmaceuticals Inc. | Award | 12,135 | - | $0 | Direct |
| Nov 11, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Sale | 5,241 | $8.43 | $44,182 | Direct |
| Nov 8, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Exercise | 17,913 | - | $0 | Direct |
| Oct 28, 2024 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
1-10 of 11 transactions